215 related articles for article (PubMed ID: 32336105)
1. Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma
Novera W; Lee ZW; Nin DS; Dai MZ; Binte Idres S; Wu H; Damen JMA; Tan TZ; Sim AYL; Long YC; Wu W; Huang RY; Deng LW
Antioxid Redox Signal; 2020 Dec; 33(17):1191-1208. PubMed ID: 32336105
[No Abstract] [Full Text] [Related]
2. Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma.
Okamoto T; Mandai M; Matsumura N; Yamaguchi K; Kondoh H; Amano Y; Baba T; Hamanishi J; Abiko K; Kosaka K; Murphy SK; Mori S; Konishi I
Mol Carcinog; 2015 Jan; 54(1):35-49. PubMed ID: 24105991
[TBL] [Abstract][Full Text] [Related]
3. Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation.
Atiya HI; Frisbie L; Goldfeld E; Orellana T; Donnellan N; Modugno F; Calderon M; Watkins S; Zhang R; Elishaev E; Soong TR; Vlad A; Coffman L
Cancer Res; 2022 Dec; 82(24):4680-4693. PubMed ID: 36219681
[TBL] [Abstract][Full Text] [Related]
4. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
[TBL] [Abstract][Full Text] [Related]
5. HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC).
Lopes-Coelho F; Gouveia-Fernandes S; Gonçalves LG; Nunes C; Faustino I; Silva F; Félix A; Pereira SA; Serpa J
Tumour Biol; 2016 Apr; 37(4):4813-29. PubMed ID: 26520442
[TBL] [Abstract][Full Text] [Related]
6. Defects in Mitochondrial Iron-Sulfur Cluster Assembly Induce Cysteine S-Polythiolation on Iron-Sulfur Apoproteins.
Christ S; Leichert LI; Willms A; Lill R; Mühlenhoff U
Antioxid Redox Signal; 2016 Jul; 25(1):28-40. PubMed ID: 26975213
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of targeting drug-based molecular biomarkers expression in ovarian clear cell carcinoma].
Li MJ; Li HR; Cheng X; Bi R; Tu XY; Liu F; Chen LH
Zhonghua Fu Chan Ke Za Zhi; 2017 Dec; 52(12):835-843. PubMed ID: 29325268
[No Abstract] [Full Text] [Related]
8. Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma.
Hsu IL; Chou CY; Wu YY; Wu JE; Liang CH; Tsai YT; Ke JY; Chen YL; Hsu KF; Hong TM
Oncotarget; 2016 Sep; 7(39):62925-62938. PubMed ID: 26910837
[TBL] [Abstract][Full Text] [Related]
9. Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.
Miyata K; Yotsumoto F; Nam SO; Odawara T; Manabe S; Ishikawa T; Itamochi H; Kigawa J; Takada S; Asahara H; Kuroki M; Miyamoto S
Cancer Med; 2014 Oct; 3(5):1159-69. PubMed ID: 25060396
[TBL] [Abstract][Full Text] [Related]
10. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I
Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075
[TBL] [Abstract][Full Text] [Related]
11. Fe-S cluster biogenesis in isolated mammalian mitochondria: coordinated use of persulfide sulfur and iron and requirements for GTP, NADH, and ATP.
Pandey A; Pain J; Ghosh AK; Dancis A; Pain D
J Biol Chem; 2015 Jan; 290(1):640-57. PubMed ID: 25398879
[TBL] [Abstract][Full Text] [Related]
12. Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction.
Mandai M; Amano Y; Yamaguchi K; Matsumura N; Baba T; Konishi I
Oncotarget; 2015 Oct; 6(31):30704-14. PubMed ID: 26375553
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria Biogenesis Modulates Iron-Sulfur Cluster Synthesis to Increase Cellular Iron Uptake.
La P; Oved JH; Ghiaccio V; Rivella S
DNA Cell Biol; 2020 May; 39(5):756-765. PubMed ID: 32282232
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria export iron-sulfur and sulfur intermediates to the cytoplasm for iron-sulfur cluster assembly and tRNA thiolation in yeast.
Pandey AK; Pain J; Dancis A; Pain D
J Biol Chem; 2019 Jun; 294(24):9489-9502. PubMed ID: 31040179
[TBL] [Abstract][Full Text] [Related]
15. Bioenergetic analysis of ovarian cancer cell lines: profiling of histological subtypes and identification of a mitochondria-defective cell line.
Dier U; Shin DH; Hemachandra LP; Uusitalo LM; Hempel N
PLoS One; 2014; 9(5):e98479. PubMed ID: 24858344
[TBL] [Abstract][Full Text] [Related]
16. Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway.
Ho CM; Huang CJ; Huang SH; Chang SF; Cheng WF
BMC Cancer; 2015 Oct; 15():789. PubMed ID: 26497956
[TBL] [Abstract][Full Text] [Related]
17. Iron-sulfur cluster biogenesis in mammalian cells: New insights into the molecular mechanisms of cluster delivery.
Maio N; Rouault TA
Biochim Biophys Acta; 2015 Jun; 1853(6):1493-512. PubMed ID: 25245479
[TBL] [Abstract][Full Text] [Related]
18. c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma.
Kim HJ; Yoon A; Ryu JY; Cho YJ; Choi JJ; Song SY; Bang H; Lee JS; Cho WC; Choi CH; Lee JW; Kim BG; Bae DS
Sci Rep; 2016 Dec; 6():38502. PubMed ID: 27917934
[TBL] [Abstract][Full Text] [Related]
19. Human Mitochondrial Ferredoxin 1 (FDX1) and Ferredoxin 2 (FDX2) Both Bind Cysteine Desulfurase and Donate Electrons for Iron-Sulfur Cluster Biosynthesis.
Cai K; Tonelli M; Frederick RO; Markley JL
Biochemistry; 2017 Jan; 56(3):487-499. PubMed ID: 28001042
[TBL] [Abstract][Full Text] [Related]
20. Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma.
Zhou H; Liu Q; Shi X; Liu Y; Cao D; Yang J
J Ovarian Res; 2020 Apr; 13(1):38. PubMed ID: 32295618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
